Vrsalovic Mislav, Zeljkovic Ivan, Presecki Ana Vrsalovic, Pintaric Hrvoje, Kruslin Bozo
School of Medicine, University of Zagreb , Zagreb , Croatia.
Blood Press. 2015;24(4):212-6. doi: 10.3109/08037051.2015.1025607. Epub 2015 May 2.
The aim of the study was to evaluate prognostic role of inflammatory biomarkers, cardiac troponin T (cTnT) and D-dimer in type A acute aortic dissection (AAD) and to examine whether they might help in risk stratification beyond values of International Registry of Acute Aortic Dissection (IRAD) score.
Baseline biomarkers were determined in 54 consecutive predominantly hypertensive patients with type A AAD and evaluated for in-hospital mortality.
After multivariable adjustment, the independent predictors of outcome were age (OR = 1.09; 95% CI 1.02-1.18), treatment strategy (OR = 0.11; 95% CI 0.02-0.06) and C-reactive protein (CRP) either as binary (OR = 7.06; 95% CI 1.34-37.36) or continuous variable (OR = 1.10; 95% CI 1.01-1.21). cTnT did not independently influence mortality. Receiver- operating characteristic (ROC) curve analysis showed significant link between CRP and outcome (area under the ROC curve, AUC = 0.79; p < 0.01). Values of CRP > 9.8 mg/l had 83% sensitivity and 80% specificity for predicting in-hospital mortality. Addition of CRP to IRAD score improved prediction of short-term outcome, AUC increased from 0.74 to 0.89 (p = 0.004).
Admission CRP has independent prognostic value in type A AAD and the addition of CRP to IRAD score improved discriminative capacity of in-hospital mortality irrespective of symptom duration and treatment strategy.
本研究旨在评估炎症生物标志物、心肌肌钙蛋白T(cTnT)和D - 二聚体在A型急性主动脉夹层(AAD)中的预后作用,并研究它们是否有助于在国际急性主动脉夹层注册研究(IRAD)评分之外进行风险分层。
对54例连续的、以高血压为主的A型AAD患者测定基线生物标志物,并评估其院内死亡率。
经过多变量调整后,结局的独立预测因素为年龄(OR = 1.09;95% CI 1.02 - 1.18)、治疗策略(OR = 0.11;95% CI 0.02 - 0.06)以及C反应蛋白(CRP),无论是作为二元变量(OR = 7.06;95% CI 1.34 - 37.36)还是连续变量(OR = 1.10;95% CI 1.01 - 1.21)。cTnT并未独立影响死亡率。受试者工作特征(ROC)曲线分析显示CRP与结局之间存在显著关联(ROC曲线下面积,AUC = 0.79;p < 0.01)。CRP > 9.8 mg/l对预测院内死亡率的敏感性为83%,特异性为80%。将CRP加入IRAD评分可改善对短期结局的预测,AUC从0.74增加至0.89(p = 0.004)。
入院时的CRP在A型AAD中具有独立的预后价值,将CRP加入IRAD评分可提高对院内死亡率的判别能力,且不受症状持续时间和治疗策略的影响。